Eric Lance, MD
Surgery · Thomasville, NCNPI 1043292345
Payments from drug & device makers
Across 65 payments — averaging $92.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Davol Inc.$406
- Boston Scientific$181
- Medtronic$91
- Conmed Corporation$89
- TELA Bio, Inc.$70
- plus $552 from 18 others
What the payments were for
- Travel & lodging$1082%
- Food & beverage$1,91532%
- Education$4,00066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $4,633 |
| Davol Inc. | 6 | $406 |
| Boston Scientific | 4 | $181 |
| Medtronic | 1 | $91 |
| Conmed Corporation | 2 | $89 |
| TELA Bio, Inc. | 2 | $70 |
| Smith+Nephew | 4 | $64 |
| Carlsmed, Inc. | 1 | $54 |
| Abbott | 2 | $48 |
| Shire North American Group Inc | 3 | $44 |
| Acell, Inc. | 1 | $35 |
| Bioventus LLC | 1 | $33 |
| Integra Lifesciences Corporation | 1 | $31 |
| Olympus America Inc. | 2 | $29 |
| CSL Behring | 1 | $29 |
| KCI USA, Inc. | 1 | $28 |
| Osiris Therapeutics Inc. | 2 | $28 |
| Organogenesis Inc. | 1 | $26 |
| Aroa Biosurgery Incorporated | 2 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $18 |
| AbbVie | 1 | $18 |
| Sanara Medtech Inc. | 1 | $14 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,000
- Phasix Mesh$110
- SpyGlass Discover$107
How this compares
$6,023 in reported general payments places this provider in the 65th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 46 | $1,482 |
| Esomeprazole Magnesium | 18 | $756 |
| Pantoprazole Sodium | 135 | $679 |
| Doxycycline Hyclate | 33 | $295 |
| Omeprazole | 11 | $265 |
| Oxycodone Hcl | 63 | $246 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $236 |
| Tramadol Hcl | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other surgery in Thomasville
- Jacob SchroderDurham$2.6M
- Samuel RossCharlotte$2.6M
- Jacob GreenbergDurham$1.3M
- Brant HenifordCharlotte$963K
- Vedra AugensteinCharlotte$789K
- William HopeWilmington$761K
- John MartinieCharlotte$712K
- Dana PortenierDurham$702K
- Dimitrios StefanidisCharlotte$697K
- Paul EnochsCary$689K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.